Dr. Christopher Bartalos, MD
Claim this profileBVL Clinical Research
Studies Crohn's Disease
Studies Ulcerative Colitis
9 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Christopher Bartalos, MD is currently running
TAK-279
for Ulcerative Colitis
The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The participants will take capsules of either TAK-279 or placebo for up to 3 months (12 weeks). Then all the participants will receive TAK-279 for the rest of the treatment part of the study (1 year or 52 weeks). During the study, participants will visit their study clinic several times.
Recruiting0 awards Phase 21 criteria
Mirikizumab
for Crohn's Disease
This trial is testing mirikizumab to see if it can help people with Crohn's disease feel better over a long time and ensure it is safe. The drug works by reducing gut inflammation.
Recruiting2 awards Phase 3
More about Christopher Bartalos, MD
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Christopher Bartalos, MD has experience with
- ABX464
- Mirikizumab
- TAK-279
- Vedolizumab
- CDPATH™
- Tofacitinib
Breakdown of trials Christopher Bartalos, MD has run
Crohn's Disease
Ulcerative Colitis
Inflammatory Bowel Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher Bartalos, MD specialize in?
Christopher Bartalos, MD focuses on Crohn's Disease and Ulcerative Colitis. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Christopher Bartalos, MD currently recruiting for clinical trials?
Yes, Christopher Bartalos, MD is currently recruiting for 7 clinical trials in Liberty Missouri. If you're interested in participating, you should apply.
Are there any treatments that Christopher Bartalos, MD has studied deeply?
Yes, Christopher Bartalos, MD has studied treatments such as ABX464, Mirikizumab, TAK-279.
What is the best way to schedule an appointment with Christopher Bartalos, MD?
Apply for one of the trials that Christopher Bartalos, MD is conducting.
What is the office address of Christopher Bartalos, MD?
The office of Christopher Bartalos, MD is located at: BVL Clinical Research, Liberty, Missouri 64068 United States. This is the address for their practice at the BVL Clinical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.